Abstract |
Three CC-chemokines-MIP-1alpha (CCL3), MIP-1beta (CCL4), and RANTES (CCL5)-are natural ligands for the human immunodeficiency virus-1 (HIV-1) coreceptor CCR5. To determine correlations between CC-chemokines and HIV-1 disease stage or response to treatment, we examined serum levels of MIP-1alpha, MIP-1beta, and RANTES in 60 infected patients during 18 months while they were taking highly active antiretroviral therapy ( HAART). Our results demonstrate that serum levels of MIP-1alpha and RANTES were increased in HIV-1-infected individuals compared with those in healthy controls. We found no significant differences among 4 clinical stages of HIV-1 infection in the serum levels of three CC-chemokines. Longitudinal HAART analyses revealed a pronounced decline in serum MIP-1alpha levels over time. We found no difference in this decline between HAART responders and nonresponders. These findings indicate that production of MIP-1alpha and RANTES changes during HIV-1 infection and treatment; however, our results suggest that serum levels of CC-chemokines should not be used as biomarkers for HIV-1 disease stage or response to treatment.
|
Authors | Ping Ye, Powel Kazanjian, Steven L Kunkel, Denise E Kirschner |
Journal | The Journal of laboratory and clinical medicine
(J Lab Clin Med)
Vol. 143
Issue 5
Pg. 310-9
(May 2004)
ISSN: 0022-2143 [Print] United States |
PMID | 15122175
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Chemokine CCL3
- Chemokine CCL4
- Chemokine CCL5
- Macrophage Inflammatory Proteins
|
Topics |
- Adult
- Antiretroviral Therapy, Highly Active
- CD4 Lymphocyte Count
- CD8-Positive T-Lymphocytes
- Chemokine CCL3
- Chemokine CCL4
- Chemokine CCL5
(blood)
- HIV Infections
(blood, drug therapy, pathology)
- HIV-1
(isolation & purification)
- Humans
- Macrophage Inflammatory Proteins
(blood)
- Male
- Middle Aged
- Treatment Outcome
- Viral Load
- Viremia
|